On our request, her surgery samples were evaluated, and 35% of the tumor was found to display elevated HER2 expression from immunohistochemistry (Fig. 6C) while the rest of the tumor was HER2-negative (Fig. 6D). The gene discussed is ERBB2; the disease is neoplasm.